E
Genetic Technologies Limited
GENE
$2.34
$0.08543.79%
E
Sell
4/12/2024Downgrade
Genetic Technologies Limited (GENE) was downgraded to E from E+ on 4/12/2024 due to a decline in the volatility index and valuation index.
Genetic Technologies Limited (GENE) was downgraded to E from E+ on 4/12/2024 due to a decline in the volatility index and valuation index.
E
Sell
3/18/2024Upgraded
Genetic Technologies Limited (GENE) was upgraded to E+ from E on 3/18/2024 due to an increase in the volatility index.
Genetic Technologies Limited (GENE) was upgraded to E+ from E on 3/18/2024 due to an increase in the volatility index.
E
Sell
3/1/2024Downgrade
Genetic Technologies Limited (GENE) was downgraded to E from E+ on 3/1/2024 due to a large decline in the growth index, volatility index and total return index. Total revenue declined 0.48% from $1.6M to $1.59M.
Genetic Technologies Limited (GENE) was downgraded to E from E+ on 3/1/2024 due to a large decline in the growth index, volatility index and total return index. Total revenue declined 0.48% from $1.6M to $1.59M.
E
Sell
3/14/2023Downgrade
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 3/14/2023 due to a decline in the growth index and solvency index. Total revenue declined 3.83% from $1.7M to $1.64M.
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 3/14/2023 due to a decline in the growth index and solvency index. Total revenue declined 3.83% from $1.7M to $1.64M.
D
Sell
2/9/2023Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index.
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 2/9/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and volatility index.
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
8/31/2022Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from D- on 8/31/2022 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 1.33% from -$557.4 to -$550, and EBIT increased 1.33% from -$1.33M to -$1.32M.
Genetic Technologies Limited (GENE) was upgraded to D from D- on 8/31/2022 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 1.33% from -$557.4 to -$550, and EBIT increased 1.33% from -$1.33M to -$1.32M.
D
Sell
6/1/2022Downgrade
Genetic Technologies Limited (GENE) was downgraded to D- from D on 6/1/2022 due to a decline in the total return index and volatility index.
Genetic Technologies Limited (GENE) was downgraded to D- from D on 6/1/2022 due to a decline in the total return index and volatility index.
D
Sell
5/16/2022Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/4/2022Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 05/04/2022.
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 04/21/2022.
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 4/20/2022 due to a large decline in the solvency index and volatility index.
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 4/20/2022 due to a large decline in the solvency index and volatility index.
D
Sell
2/17/2022Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from D- on 2/17/2022 due to an increase in the volatility index.
Genetic Technologies Limited (GENE) was upgraded to D from D- on 2/17/2022 due to an increase in the volatility index.
D
Sell
1/26/2022Downgrade
Genetic Technologies Limited (GENE) was downgraded to D- from D on 1/26/2022 due to a noticeable decline in the total return index.
Genetic Technologies Limited (GENE) was downgraded to D- from D on 1/26/2022 due to a noticeable decline in the total return index.
D
Sell
11/9/2021Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 11/09/2021.
Genetic Technologies Limited (GENE) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and growth index. Total revenue declined 0.25% from $40.2 to $40.1.
Genetic Technologies Limited (GENE) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and growth index. Total revenue declined 0.25% from $40.2 to $40.1.
D
Sell
7/15/2020Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from D- on 7/15/2020 due to an increase in the volatility index and total return index.
Genetic Technologies Limited (GENE) was upgraded to D from D- on 7/15/2020 due to an increase in the volatility index and total return index.
D
Sell
6/5/2020Downgrade
Genetic Technologies Limited (GENE) was downgraded to D- from D on 6/5/2020 due to a decline in the volatility index and total return index.
Genetic Technologies Limited (GENE) was downgraded to D- from D on 6/5/2020 due to a decline in the volatility index and total return index.
D
Sell
5/1/2020Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index, total return index and solvency index.
Genetic Technologies Limited (GENE) was upgraded to D from D- on 5/1/2020 due to an increase in the volatility index, total return index and solvency index.
D
Sell
1/9/2020Upgraded
Genetic Technologies Limited (GENE) was upgraded to D- from E+ on 1/9/2020 due to an increase in the efficiency index. Net income increased 1.72% from -$1.18M to -$1.16M.
Genetic Technologies Limited (GENE) was upgraded to D- from E+ on 1/9/2020 due to an increase in the efficiency index. Net income increased 1.72% from -$1.18M to -$1.16M.
E
Sell
5/30/2018Downgrade
Genetic Technologies Limited (GENE) was downgraded to E+ from D- on 5/30/2018 due to a decline in the solvency index and efficiency index. Total capital declined 0.43% from $5.75M to $5.73M.
Genetic Technologies Limited (GENE) was downgraded to E+ from D- on 5/30/2018 due to a decline in the solvency index and efficiency index. Total capital declined 0.43% from $5.75M to $5.73M.
D
Sell
1/31/2018Upgraded
Genetic Technologies Limited (GENE) was upgraded to D- from E+ on 1/31/2018 due to an increase in the total return index, volatility index and solvency index.
Genetic Technologies Limited (GENE) was upgraded to D- from E+ on 1/31/2018 due to an increase in the total return index, volatility index and solvency index.
E
Sell
1/10/2017Downgrade
Genetic Technologies Limited (GENE) was downgraded to E+ from D- on 1/10/2017 due to a major decline in the solvency index, valuation index and volatility index.
Genetic Technologies Limited (GENE) was downgraded to E+ from D- on 1/10/2017 due to a major decline in the solvency index, valuation index and volatility index.
D
Sell
3/11/2016Downgrade
Genetic Technologies Limited (GENE) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index, total return index and growth index. Total revenue declined 0.77% from $142.6 to $141.5.
Genetic Technologies Limited (GENE) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index, total return index and growth index. Total revenue declined 0.77% from $142.6 to $141.5.
D
Sell
6/12/2015Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from D- on 6/12/2015 due to an increase in the solvency index, valuation index and growth index.
Genetic Technologies Limited (GENE) was upgraded to D from D- on 6/12/2015 due to an increase in the solvency index, valuation index and growth index.
D
Sell
2/27/2015Downgrade
Genetic Technologies Limited (GENE) was downgraded to D- from D on 2/27/2015 due to a large decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 1.35 to 5.18, total capital declined 63.88% from $4.08M to $1.48M, and the quick ratio declined from 1.7 to 1.34.
Genetic Technologies Limited (GENE) was downgraded to D- from D on 2/27/2015 due to a large decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 1.35 to 5.18, total capital declined 63.88% from $4.08M to $1.48M, and the quick ratio declined from 1.7 to 1.34.
D
Sell
7/24/2014Upgraded
Genetic Technologies Limited (GENE) was upgraded to D from D- on 7/24/2014 due to an increase in the valuation index.
Genetic Technologies Limited (GENE) was upgraded to D from D- on 7/24/2014 due to an increase in the valuation index.
D
Sell
4/22/2014Downgrade
Genetic Technologies Limited (GENE) was downgraded to D- from D on 4/22/2014 due to a substantial decline in the solvency index, total return index and valuation index. Debt to equity increased from 0.72 to 0.76.
Genetic Technologies Limited (GENE) was downgraded to D- from D on 4/22/2014 due to a substantial decline in the solvency index, total return index and valuation index. Debt to equity increased from 0.72 to 0.76.
NASDAQ
05/06/2024 11:22AM Eastern
Quotes delayed
